We believe this site might serve you best::

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Proteasome-Glo™ Assay Systems Technical Bulletin

Instructions for Use of Product(s)
G8531, G8532, G8621, G8622, G8631, G8632, G8641, G8642
Literature # TB349

The Proteasome-Glo™ 3-Substrate System consists of three homogeneous bioluminescent assays that measure the three proteolytic activities associated with the proteasome (each of these three assays is available separately). The Proteasome-Glo™ 3-Substrate System provides three separate assays that differ in their ability to detect different protease activities based on their substrate components. The luminogenic substrates provided for the chymotrypsin-like, trypsin-like, and caspase-like activities are Suc-LLVY-aminoluciferin, Z-LRR-aminoluciferin, and Z-nLPnLD-aminoluciferin, respectively. Each substrate is added to a buffer system optimized for proteasome activity and luciferase activity to make a Proteasome-Glo™ Reagent for a particular catalytic activity. The individual Proteasome-Glo™ Reagent is added to test samples in an "add-mix-measure" format, resulting in proteasome-induced cleavage of the particular substrate. Substrate cleavage generates a "glow-type" luminescent signal produced by the luciferase reaction. In this homogeneous coupled-enzyme format, the signal is proportional to proteasome activity.

Summary of Changes
The following changes were made to the 1/16 revision of this document:
1. Patent and disclaimer statements were updated.
2. The document design was updated.

Printed in USA. Revised 1/16.

Choose your country

Americas

Brazil
Brazil
Canada
Canada
United States
United States

Pacific Asia

Australia
Australia
India
India
Japan
Japan
Korea, Republic of
Korea, Republic of
Singapore
Singapore

Europe

Austria
Austria
Belgium
Belgium
Denmark
Denmark
Estonia
Estonia
Finland
Finland
France
France
Germany
Germany
Iceland
Iceland
Italy
Italy
Luxembourg
Luxembourg
Netherlands
Netherlands
Norway
Norway
Poland
Poland
Spain
Spain
Sweden
Sweden
Switzerland
Switzerland
United Kingdom
United Kingdom